@article{ATM16126,
author = {Maria Gonzalez-Cao and Alfonso Berrocal and Susana Puig and Niki Karachaliou and Leticia De Matos-Arruda and Joan Seoane and David Escors and Carmen Alvarez and Jose Pedro Vaque and Aleix Prat and Claudia Wellbrock and Imanol Arozarena and Ivan Marquez-Rodas and Enrique Espinosa and Migue Angel Molina and Teresa Puertolas and Manuel Juan-Otero and Rosina Malagrida and Eloisa Jantus-Lewintre and Virtudes Soriano and Ana Arance and Jose Luis Manzano and Paul Lorigan and Thomas F. Gajewski and Rafael Rosell and On behalf of the Spanish Melanoma Group (GEM)},
title = {Report from the II melanoma translational meeting of the Spanish Melanoma Group (GEM)},
journal = {Annals of Translational Medicine},
volume = {5},
number = {19},
year = {2017},
keywords = {},
abstract = {The II melanoma translational meeting of the Spanish Melanoma Group (GEM) was held in Barcelona, Spain, at the Hospital Universitari Quiron-Dexeus on November 3rd, 2016. The conference featured leaders in the fields of oncology, immunology and dermatology, all working at both national and international levels on basic research with direct applications to the clinical setting. The objective was to present cutting edge research on melanoma, mainly from Spanish research groups, but also from some international groups, with the aim of generating a network for future national and international collaborations. During a single day, fifteen speakers, seven biologists and eight clinicians, with a special focus on translational research, outlined the main findings of their ongoing studies. The moderators in every session were recognized GEM oncologists who guided discussion from the clinical point of view regarding the preclinical data presented. Herein, we summarize the main topics discussed during the meeting.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/16126}
}